Physician profile
John A Russell
NPI 1619925294
$2,249.48
in general payments reported to CMS, 2019-2025
35 companies · $234 in 2025
The $234 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $124 · 2021: $457 · 2022: $543 · 2023: $396 · 2024: $201 · 2025: $234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.15 | 2019-2025 | Liletta, Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $290.72 | 2020-2025 | Veozah |
| Exeltis, USA INC. | $207.77 | 2022-2025 | Slynd |
| Organon LLC | $108.57 | 2021-2025 | Jada System |
| Hologic Sales and Service, LLC | $82.46 | 2019-2022 | |
| Daiichi Sankyo INC. | $68.14 | 2019-2023 | Injectafer |
| Agile Therapeutics, INC. | $65.10 | 2021-2022 | |
| Myovant Sciences INC. | $62.81 | 2021-2022 | |
| Channel Medsystems, INC. | $58.98 | 2022 | |
| Pfizer INC. | $58.51 | 2019-2024 | |
| Therapeuticsmd, INC. | $57.63 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.19 | 2020-2025 | |
| Smith+Nephew, INC. | $47.96 | 2022-2025 | Pico, Acticoat 4" X 4" |
| Mylan Pharmaceuticals INC. | $47.21 | 2021-2022 | |
| Aspira Women'S Health INC | $38.76 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $37.48 | 2024-2025 | |
| Sage Therapeutics, LLC | $34.27 | 2024-2025 | Zurzuvae |
| Intuitive Surgical, INC. | $32.29 | 2020 | |
| Becton, Dickinson and Company | $27.28 | 2023 | |
| Kedrion Biopharma, INC. | $24.76 | 2025 | Koate, Kedrab, Gammaked |
| Amag Pharmaceuticals, INC. | $24.73 | 2019 | |
| Hydrofera LLC | $21.46 | 2025 | Cutimed Sorbact |
| Heron Therapeutics, INC. | $21.22 | 2022 | |
| Sumitomo Pharma America, INC. | $19.43 | 2023 | Myfembree |
| Covidien LP | $18.96 | 2020 | |
| Davol INC. | $18.32 | 2021 | |
| Optumhealth Care Solutions, LLC | $17.97 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Evofem Biosciences, INC. | $17.61 | 2021 | |
| Roche Diagnostics Corporation | $16.44 | 2019 | |
| Shield Therapeutics INC | $15.52 | 2024 | |
| Minerva Surgical, INC | $14.44 | 2022 | |
| Urovant Sciences INC | $13.09 | 2021 | |
| Amgen INC. | $11.80 | 2019 | |
| Avion Pharmaceuticals | $11.37 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.